Search

everythinglearnresearchcommunity

for

Search:↓

New treatments targeting T-cell pathways are needed for better alopecia areata management.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Some nonsurgical hair loss treatments are effective, especially if started early.

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.

Cosmeceuticals may have potential but their effectiveness and market success are still uncertain.

Low-dose oral and sublingual minoxidil seem safe for children with hair disorders.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Dutasteride is more effective than finasteride for hair loss but may affect male fertility and should be used cautiously.

Some treatments for severe hair loss work but often have side effects, with baricitinib showing the most promise.

Polycystic ovary syndrome (PCOS) affects about 10% of women, is often linked to obesity and family history, and can cause irregular periods, fertility issues, and other symptoms. It's usually managed with lifestyle changes, weight loss, and medication.

Old drugs can be used for new treatments, saving time and money, but there are challenges like needing more evidence and legal concerns.

Imiquimod may be a better non-surgical treatment for cervical pre-cancer, but its effectiveness for vaginal pre-cancer is unclear, and it has some side effects.

Medicines called 5-alpha-reductase inhibitors, like finasteride and dutasteride, are useful for treating enlarged prostate and male pattern hair loss.

The document concludes that women should not use 5-alpha-reductase inhibitors due to the risk of birth defects and limited effectiveness.

The review found that women using hair loss drugs like finasteride and dutasteride rarely reported sexual side effects.

The document lists various dermatology topics, treatments, and diagnostic methods.

5 alpha reductase inhibitors can cause sexual, cognitive, and muscle side effects, and may slightly increase aggressive cancer risk.

Adding stromal vascular fraction to platelet-rich plasma injections did not significantly improve hair growth in androgenetic alopecia treatment.

Spironolactone does not increase cancer risk and may lower prostate cancer risk, but more research is needed.

People with common hair loss conditions may have a higher risk of heart disease and related health issues.

The document explains hair biology, the causes of hair loss, and reviews various hair loss treatments.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

Up to 50% of women may experience significant hair loss by age 50, with various causes and treatments available.

Testosterone Replacement Therapy can improve sexual health in postmenopausal women with low sexual desire, but more research is needed on its long-term effects.

Sodium valproate can cause reversible hair loss in some patients.

The document concludes that gender-affirming treatments are essential for transgender individuals and outlines safe hormone therapy practices.

9-cis-retinoic acid showed some effectiveness in treating AIDS-related Kaposi sarcoma but had significant side effects at higher doses.

PRP can help treat hair loss but needs standardized methods for best results.

The medication cyproterone acetate/ethinylestradiol is usually prescribed correctly for acne after other treatments don't work.